Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti‐CD52 monoclonal antibody alemtuzumab (Campath‐1H) (Q46113074)
Jump to navigation
Jump to search
scientific article published on October 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti‐CD52 monoclonal antibody alemtuzumab (Campath‐1H) |
scientific article published on October 1, 2003 |
Statements
1 reference
Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti‐CD52 monoclonal antibody alemtuzumab (Campath‐1H) (English)
Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) (English)
Xiuqing Ru
1 reference
1 October 2003
1 reference
123
1 reference
2
1 reference
278-281
1 reference
1 reference
1 reference
Identifiers
1 reference